Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai
External link for Paige
11 Times Square
New York City, New York 10036, US
Paige reposted this
Paige needed a way to manage, store, and analyze its vast library of cancer images to build AI solutions at scale. A data migration to Microsoft Azure enabled the NYC-based team to build diagnostic AI applications that help pathologists around the world make quicker, more informed decisions. With AI and Microsoft Azure, Paige is accelerating cancer diagnoses to improve patient outcomes.
Paul van Diest, MD, PhD, has been a dedicated researcher since the start of his career, most recently becoming active in the field of implementing digital pathology and AI and advocating for its use by more individuals across the industry. We were honored to have Dr. van Diest join us this month on Inside Pathology, where he dispels common misconceptions about pathology AI, shares best practices for implementation, and talks about his current research project, CONFIDENT. https://hubs.ly/Q02Db2bc0
A new published study found that support from Paige Breast Lymph Node, the latest Paige AI application to earn FDA breakthrough designation, has been proven to reduce overall reading time per slide and enhance pathologist sensitvity. Explore the full findings and what this could mean for real world practice. https://hubs.ly/Q02BJht80
Director of AI Science, SIQI LIU is speaking at next week's IEEE Workshop on Computer Vision for Microscopy Image Analysis (CVMI). He'll be discussing Paige's Foundation Model approach, how our models including Virchow and PRISM achieve state-of-the-art performance, and the potential this technology holds for precision medicine.
Foundation Models learn by analyzing small tiles within larger images, or embeddings as they are more commonly called, which provide near limitless possibilities for use in understanding cancer - our new blog breaks down how Paige's embeddings services can empower a range of projects from biomarker discovery to outcome prediction and more. https://hubs.ly/Q02BHK-S0
Paige Foundation Model technology - now available to accelerate drug discovery and cancer treatment - was spotlighted in Breaking Cancer News, where Andy Moye, PhD and Razik Yousfi shared their takes on how this technology will impact global patient care: https://lnkd.in/eqQiHKiR Jamie Reno Teen Cancer America
National Cancer Survivors Day is a celebration for those who have survived, an inspiration for those recently diagnosed, a gathering of support for families, and an outreach to the community - and Paige is incredibly proud to join in this important day and continue to fight to make sure more patients not just survive but thrive. #NCSD2024 #CancerSurvivorsDay #NCSD National Cancer Survivors Day Foundation, Inc.
Paige is putting analytical data for advanced multi-tissue cancer and rare cancer detection, biomarker identification, cellular subtyping, spatial biology, and therapy response prediction into the hands of pharmaceutical companies to power the next generation of precision treatment through our new service, which we'll be showcasing at ASCO. Visit Innovation Hub booth #8 to learn more. #ASCO24
In a new clinical study of Paige Breast Lymph Node, published in the American Journal of Surgical Pathology, our AI application was shown to support pathologists in accelerating their efficiency by 55% and enhancing sensitivity by 25.5% https://hubs.ly/Q02y_cCm0
Paige is thrilled to announce a new service that delivers the power of our Foundation Model technology to pharmaceutical and life sciences companies to support the development of custom AI models for R&D, clinical trials, experimental studies, commercial needs and more. “Paige’s Foundation Models are powerful pre-trained technologies that now put AI capabilities at the fingertips of pharmaceutical companies, representing a significant step forward for drug discovery and development.” https://hubs.ly/Q02y-HFr0